Renoprotective therapy: titration against urinary protein excretion
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 354 (9176) , 352-353
- https://doi.org/10.1016/s0140-6736(99)90122-8
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazideNephrology Dialysis Transplantation, 1998
- ACE-inhibitors: panacea for progressive renal disease?The Lancet, 1997
- Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathyThe Lancet, 1997
- Blood Pressure Control, Proteinuria, and the Progression of Renal DiseaseAnnals of Internal Medicine, 1995
- Additive antiproteinuric effect of ACE inhibition and a low-protein diet in human renal diseaseNephrology Dialysis Transplantation, 1995
- Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatmentDiabetologia, 1994
- Is the antiproteinuric effect of ACE inhibition mediated by intereference in the renin-angiotensin system?Kidney International, 1994
- Additive antiproteinuric effect of angiotensin-converting enzyme inhibition and non-steroidal anti-inflammatory drug therapy: A clue to the mechanism of actionClinical Science, 1991
- Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinoprilKidney International, 1989
- Selective effect of low protein diets in chronic renal diseases.BMJ, 1984